Navigation Links
Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes

PRINCETON, N.J., Sept. 24 /PRNewswire-FirstCall/ -- Novo Nordisk, a world leader in diabetes care, announced that effective today, the company is listed in the Dow Jones Sustainability World Index (DJSI World) as best-in-class in the healthcare industry -- one of 18 global supersectors analyzed.

The latest global analysis of corporate sustainability leadership was based on a thorough analysis of companies' economic, environmental and social performance, assessing issues including corporate governance, risk management, branding, climate change, supply chain standards and labor practices.

The report concludes "Novo Nordisk is the leading company in terms of sustainability in the pharmaceutical industry. Sustainability is an integral part of its corporate strategy and business organization."

The report continues, "Novo Nordisk is particularly strong in the social dimension where it achieved the industry top ratings in human capital development, corporate citizenship/philanthropy, and social reporting." The company's responsible sourcing, environmental management, bioethics and climate strategy also achieve high scores.

"This honor provides us further encouragement for operating our business according to our Triple Bottom Line philosophy -- a company that can be economically vital, as well as socially and environmentally responsible," said Martin Sorters, president, Novo Nordisk in the United States.

"Our passion for changing diabetes is supported by an understanding that sustainability in business is not just possible but necessary. By putting the patient at the center of all we do -- from providing the best therapies to patients and advocating our employees' volunteerism with patient groups and at diabetes camps to our environmental stewardship through water conservation efforts and our climate change strategy -- we strive to be successful and responsible."

The indexes, which currently comprise USD$5.6 billion assets under management, are used as a tool by asset managers in 15 countries to guide their investment decisions.

Novo Nordisk has been a component of the Dow Jones Sustainability Indexes every year since the launch in 1999.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 84-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 25,000 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit; for United States information, visit

Further information:

Media: Investors:

Sean Clements Christian Qvist Frandsen

Tel: 609 514 8316 Tel: 609 919 7937

SOURCE Novo Nordisk
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ontario Ranks Highest in Free Bird Flu Vaccination Rates
2. Imbalance In Gender Ratio Addressed By Religious Leaders
3. Religious Leaders condemn determination of sex in hospitals
4. Need For Social Churning Emphasized In CMC Meet On ‘Leadership In Healthcare
5. North-Eastern Leaders Of India Meet To Discuss HIV Problems
6. Cheerleaders run high risk of injury-US study
7. Muslim Leaders’ Help Sought To Discourage Smokin
8. India needs dental health leadership, says expert
9. Freedom Fighter And Orissa Congress Leader Dies Of Chest Pain
10. Religious Leaders Come In The Way Of Euthanasia
11. Learn From a Leader: Smitherman shares a personal story about his battle with drugs
Post Your Comments:
(Date:11/25/2015)... ... , ... Smiles by Stevens is pleased to announce the addition ... many patients are aware of the benefits of Botox® in the treatment of moderate ... with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) ...
(Date:11/25/2015)... , ... November 25, 2015 , ... “While riding the ... inventor, from Bronx, N.Y. “I thought there had to be a convenient and comfortable ... PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or inclement ...
(Date:11/25/2015)... ... 25, 2015 , ... Privately owned Contract Development and Manufacturing ... its current state of the art research, development and manufacturing facility outside of ... manufacturing capacity as well as to support its clients’ growing research and development ...
(Date:11/25/2015)... Mateo, CA (PRWEB) , ... November 25, 2015 , ... ... in prizes were awarded to winners of the Create Real Impact awards. California ... creative expression to help stem the tide of distracted and reckless driving, the number ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to seek treatment ... dental implants at her Mississauga, ON practice. Dr. Williams has been providing dental ... dental implants. , Missing teeth can lead to a variety of complications if ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... COMMACK , Nueva York ... Avery Biomedical Devices (ABD), fabricante del Avery Breathing ... Anders Jonzon , MD; Ph.D. como consultor ...   --> Foto - ... --> El doctor Jonzon es un ...
(Date:11/24/2015)... 2015 Sectra (STO: SECT B) ... into a multi-year agreement to deploy Breast Imaging ... provide the Breast Center a future-proof platform capable of ... SECT B) announces that Breast Center of Acadiana ... Breast Imaging PACS in its two freestanding imaging centers. This ...
(Date:11/24/2015)... and BERN, Switzerland , November 24, ... Center for Biomedical Engineering Research of the University of ... of Endocrinology, Diabetes and Clinical Nutrition of the Bern ... of an exclusive collaboration to develop a novel generation ... the personalised delivery of insulin for diabetic patients with ...
Breaking Medicine Technology: